IDEXX Laboratories, Inc. (BMV:IDXX)

Market Cap	801.45B
Revenue (ttm)	80.36B
Net Income (ttm)	18.29B
Shares Out	n/a
EPS (ttm)	221.05
PE Ratio	43.81
Forward PE	42.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25
Average Volume	36
Open	10,210
Previous Close	10,000
Day's Range	10,210 - 10,210
52-Week Range	7,650 - 10,210
Beta	n/a
RSI	65.69
Earnings Date	Aug 4, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: IDXX

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD